All In Biotech

Drug Trial Radar · NCT04481321

Clinical and Molecular Study of Endometriosis and Adenomyosis

ENDOCHAP Monocentric Cohort: Clinical and Molecular Study of Endometriosis and Adenomyosis

Last checked: Nov 20, 2026Latest source record: Nov 20, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

5,300

Planned (sponsor's estimate)

Start

May 2006

Primary completion

Jun 2040

Study completion Dec 2040

Sponsor

Lead sponsor
Assistance Publique - Hôpitaux de ParisAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
URC-CIC Paris Descartes Necker Cochin
First posted
Jul 22, 2020

More drug trials from this sponsor

Design

Study type
Observational
FDA-regulated drug
No
Who can join
Female only, from 18 years, up to 42 years

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether endometriosis and adenomyosis are progressive diseases, in terms of symptoms (pain, abnormal uterine bleeding and infertility), anatomical lesions size, and recurrences. We also aimed to address molecular questions on immune dialogues between ectopic lesions and the eutopic endometrium, auto-immunity in endometriosis and adenomyosis and the role of the microbiota in their respective pathophysiologies.

Conditions

  • Endometriosis
  • Adenomyosis

Interventions

  • Biological/VaccineBiological

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pain scores (analog visual scale), quantification of uterine bleeding (number of towels or tampon/day/month) and live birth ratesTime frame: 10 years
  2. Changes in lesions or recurrences to imaging performed during the gynaecological follow-up of the patientTime frame: 10 years

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Port Royal, hospital cochin

    Paris, France · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.